Trial NCT02384954

View at ClinicalTrials.gov 
Org. Study IDs: CA-ALT-803-02-14

Last trial update was posted on 2021-02-15

MeSH Interventions

Rituximab

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Non-Hodgkin

Other Conditions

Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma

Stopping Reasons

Change in drug product development strategy.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID